{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:24:29Z","timestamp":1772162669364,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01807-8","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T12:10:23Z","timestamp":1755087023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Metabolic reprogramming of arachidonic acid in clear cell renal carcinoma promotes an immunosuppressive microenvironment by activating MDK signaling pathway"],"prefix":"10.1007","volume":"25","author":[{"given":"Jiaxi","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junfeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"1807_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"1807_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"key":"1807_CR3","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3322\/caac.21411","volume":"67","author":"PC Barata","year":"2017","unstructured":"Barata PC, Rini BI. Treatment of renal cell carcinoma: current status and future directions. CA Cancer J Clin. 2017;67:507\u201324. https:\/\/doi.org\/10.3322\/caac.21411.","journal-title":"CA Cancer J Clin"},{"key":"1807_CR4","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","volume":"3","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh JJ, et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3:17009. https:\/\/doi.org\/10.1038\/nrdp.2017.9.","journal-title":"Nat Rev Dis Primers"},{"key":"1807_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411691","author":"M Montecillo-Aguado","year":"2023","unstructured":"Montecillo-Aguado M, Tirado-Rodriguez B, Huerta-Yepez S. The involvement of polyunsaturated fatty acids in apoptosis mechanisms and their implications in cancer. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241411691.","journal-title":"Int J Mol Sci"},{"key":"1807_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28114316","author":"C Ortiz-Plac\u00edn","year":"2023","unstructured":"Ortiz-Plac\u00edn C, Castillejo-Rufo A, Estar\u00e1s M, Gonz\u00e1lez A. Membrane lipid derivatives: roles of arachidonic acid and its metabolites in pancreatic physiology and pathophysiology. Molecules. 2023. https:\/\/doi.org\/10.3390\/molecules28114316.","journal-title":"Molecules"},{"key":"1807_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00432-002-0365-y","volume":"128","author":"HM Schuller","year":"2002","unstructured":"Schuller HM, et al. The cyclooxygenase inhibitor ibuprofen and the FLAP inhibitor MK886 inhibit pancreatic carcinogenesis induced in hamsters by transplacental exposure to ethanol and the tobacco carcinogen NNK. J Cancer Res Clin Oncol. 2002;128:525\u201332. https:\/\/doi.org\/10.1007\/s00432-002-0365-y.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1807_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108455","volume":"248","author":"H Yang","year":"2023","unstructured":"Yang H, et al. Regulation of inflammation in cancer by dietary eicosanoids. Pharmacol Ther. 2023;248: 108455. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108455.","journal-title":"Pharmacol Ther"},{"key":"1807_CR9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"key":"1807_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/sjg.SJG_390_18","volume":"25","author":"K Shadhu","year":"2019","unstructured":"Shadhu K, Xi C. Inflammation and pancreatic cancer: an updated review. Saudi J Gastroenterol. 2019;25:3\u201313. https:\/\/doi.org\/10.4103\/sjg.SJG_390_18.","journal-title":"Saudi J Gastroenterol"},{"key":"1807_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107670","volume":"218","author":"A Fishbein","year":"2021","unstructured":"Fishbein A, Hammock BD, Serhan CN, Panigrahy D. Carcinogenesis: failure of resolution of inflammation? Pharmacol Ther. 2021;218: 107670. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107670.","journal-title":"Pharmacol Ther"},{"key":"1807_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10555-018-9742-0","volume":"37","author":"W Kim","year":"2018","unstructured":"Kim W, Son B, Lee S, Do H, Youn B. Targeting the enzymes involved in arachidonic acid metabolism to improve radiotherapy. Cancer Metastasis Rev. 2018;37:213\u201325. https:\/\/doi.org\/10.1007\/s10555-018-9742-0.","journal-title":"Cancer Metastasis Rev"},{"key":"1807_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13428","volume":"56","author":"Y Chen","year":"2023","unstructured":"Chen Y, et al. Epigenetic regulation of chemokine (CC-motif) ligand 2 in inflammatory diseases. Cell Prolif. 2023;56: e13428. https:\/\/doi.org\/10.1111\/cpr.13428.","journal-title":"Cell Prolif"},{"key":"1807_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2023.01.008","author":"L Falkowski","year":"2023","unstructured":"Falkowski L, Buddenkotte J, Datsi A. Epigenetics in T-cell driven inflammation and cancer. Semin Cell Dev Biol. 2023. https:\/\/doi.org\/10.1016\/j.semcdb.2023.01.008.","journal-title":"Semin Cell Dev Biol"},{"key":"1807_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108739","author":"M Saikia","year":"2023","unstructured":"Saikia M, Cheung N, Singh AK, Kapoor V. Role of midkine in cancer drug resistance: regulators of its expression and its molecular targeting. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24108739.","journal-title":"Int J Mol Sci"},{"key":"1807_CR16","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1100\/2011\/517152","volume":"11","author":"LT Weckbach","year":"2011","unstructured":"Weckbach LT, Muramatsu T, Walzog B. Midkine in inflammation. ScientificWorldJournal. 2011;11:2491\u2013505. https:\/\/doi.org\/10.1100\/2011\/517152.","journal-title":"ScientificWorldJournal"},{"key":"1807_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/s0304-3835(03)00450-6","volume":"204","author":"K Kadomatsu","year":"2004","unstructured":"Kadomatsu K, Muramatsu T. Midkine and pleiotrophin in neural development and cancer. Cancer Lett. 2004;204:127\u201343. https:\/\/doi.org\/10.1016\/s0304-3835(03)00450-6.","journal-title":"Cancer Lett"},{"key":"1807_CR18","doi-asserted-by":"publisher","first-page":"12474","DOI":"10.1074\/jbc.274.18.12474","volume":"274","author":"N Maeda","year":"1999","unstructured":"Maeda N, et al. A receptor-like protein-tyrosine phosphatase PTPzeta\/RPTPbeta binds a heparin-binding growth factor midkine. Involvement of arginine 78 of midkine in the high affinity binding to PTPzeta. J Biol Chem. 1999;274:12474\u20139. https:\/\/doi.org\/10.1074\/jbc.274.18.12474.","journal-title":"J Biol Chem"},{"key":"1807_CR19","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1006\/bbrc.2000.2549","volume":"270","author":"H Muramatsu","year":"2000","unstructured":"Muramatsu H, et al. LDL receptor-related protein as a component of the midkine receptor. Biochem Biophys Res Commun. 2000;270:936\u201341. https:\/\/doi.org\/10.1006\/bbrc.2000.2549.","journal-title":"Biochem Biophys Res Commun"},{"key":"1807_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11010008","author":"Q Liu","year":"2022","unstructured":"Liu Q, et al. Combined usage of MDK inhibitor augments interferon-\u03b3 anti-tumor activity in the SKOV3 human ovarian cancer cell line. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines11010008.","journal-title":"Biomedicines"},{"key":"1807_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116282","volume":"9","author":"M Haffner-Luntzer","year":"2014","unstructured":"Haffner-Luntzer M, et al. Midkine-deficiency delays chondrogenesis during the early phase of fracture healing in mice. PLoS ONE. 2014;9: e116282. https:\/\/doi.org\/10.1371\/journal.pone.0116282.","journal-title":"PLoS ONE"},{"key":"1807_CR22","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s00262-012-1235-3","volume":"61","author":"S Zhao","year":"2012","unstructured":"Zhao S, et al. Midkine upregulates MICA\/B expression in human gastric cancer cells and decreases natural killer cell cytotoxicity. Cancer Immunol Immunother. 2012;61:1745\u201353. https:\/\/doi.org\/10.1007\/s00262-012-1235-3.","journal-title":"Cancer Immunol Immunother"},{"key":"1807_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01392-3","volume":"9","author":"L Ding","year":"2023","unstructured":"Ding L, et al. Midkine inhibition enhances anti-PD-1 immunotherapy in sorafenib-treated hepatocellular carcinoma via preventing immunosuppressive MDSCs infiltration. Cell Death Discov. 2023;9: 92. https:\/\/doi.org\/10.1038\/s41420-023-01392-3.","journal-title":"Cell Death Discov"},{"key":"1807_CR24","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/s41591-020-1073-3","volume":"26","author":"D Cerezo-Wallis","year":"2020","unstructured":"Cerezo-Wallis D, et al. Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state. Nat Med. 2020;26:1865\u201377. https:\/\/doi.org\/10.1038\/s41591-020-1073-3.","journal-title":"Nat Med"},{"key":"1807_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01392-w","volume":"20","author":"J Xu","year":"2021","unstructured":"Xu J, Liao K, Yang X, Wu C, Wu W. Using single-cell sequencing technology to detect circulating tumor cells in solid tumors. Mol Cancer. 2021;20: 104. https:\/\/doi.org\/10.1186\/s12943-021-01392-w.","journal-title":"Mol Cancer"},{"key":"1807_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13045-021-01105-2","volume":"14","author":"Y Lei","year":"2021","unstructured":"Lei Y, et al. Applications of single-cell sequencing in cancer research: progress and perspectives. J Hematol Oncol. 2021;14:91. https:\/\/doi.org\/10.1186\/s13045-021-01105-2.","journal-title":"J Hematol Oncol"},{"key":"1807_CR27","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41587-021-01091-3","volume":"40","author":"D Sun","year":"2022","unstructured":"Sun D, et al. Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data. Nat Biotechnol. 2022;40:527\u201338. https:\/\/doi.org\/10.1038\/s41587-021-01091-3.","journal-title":"Nat Biotechnol"},{"key":"1807_CR28","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10350","volume":"476","author":"R Possemato","year":"2011","unstructured":"Possemato R, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature. 2011;476:346\u201350. https:\/\/doi.org\/10.1038\/nature10350.","journal-title":"Nature"},{"key":"1807_CR29","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1471-2105-11-367","volume":"11","author":"R Gaujoux","year":"2010","unstructured":"Gaujoux R, Seoighe C. A flexible R package for nonnegative matrix factorization. BMC Bioinformatics. 2010;11:367. https:\/\/doi.org\/10.1186\/1471-2105-11-367.","journal-title":"BMC Bioinformatics"},{"key":"1807_CR30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243\u201359. https:\/\/doi.org\/10.1007\/978-1-4939-7493-1_12.","journal-title":"Methods Mol Biol"},{"key":"1807_CR31","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, et al. Fast, sensitive and accurate integration of single-cell data with harmony. Nat Methods. 2019;16:1289\u201396. https:\/\/doi.org\/10.1038\/s41592-019-0619-0.","journal-title":"Nat Methods"},{"key":"1807_CR32","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573-3587.e3529. https:\/\/doi.org\/10.1016\/j.cell.2021.04.048.","journal-title":"Cell"},{"key":"1807_CR33","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","volume":"171","author":"SV Puram","year":"2017","unstructured":"Puram SV, et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell. 2017;171:1611-1624.e1624. https:\/\/doi.org\/10.1016\/j.cell.2017.10.044.","journal-title":"Cell"},{"key":"1807_CR34","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41587-021-01091-3","volume":"40","author":"D Sun","year":"2022","unstructured":"Sun D, et al. Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data. Nat Biotechnol. 2022;40:527\u201338. https:\/\/doi.org\/10.1038\/s41587-021-01091-3.","journal-title":"Nat Biotechnol"},{"key":"1807_CR35","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S, et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods. 2017;14:1083\u20136. https:\/\/doi.org\/10.1038\/nmeth.4463.","journal-title":"Nat Methods"},{"key":"1807_CR36","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, et al. Inference and analysis of cell-cell communication using Cell Chat. Nat Commun. 2021;12:1088. https:\/\/doi.org\/10.1038\/s41467-021-21246-9.","journal-title":"Nat Commun"},{"key":"1807_CR37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejca.2022.03.038","volume":"169","author":"S Ortiz-Cuaran","year":"2022","unstructured":"Ortiz-Cuaran S, et al. Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer. Eur J Cancer. 2022;169:106\u201322. https:\/\/doi.org\/10.1016\/j.ejca.2022.03.038.","journal-title":"Eur J Cancer"},{"key":"1807_CR38","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.1172\/jci123360","volume":"128","author":"JD Klement","year":"2018","unstructured":"Klement JD, et al. An osteopontin\/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion. J Clin Invest. 2018;128:5549\u201360. https:\/\/doi.org\/10.1172\/jci123360.","journal-title":"J Clin Invest"},{"key":"1807_CR39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-023-01478-6","volume":"16","author":"M Li","year":"2023","unstructured":"Li M, et al. Metabolism, metabolites, and macrophages in cancer. J Hematol Oncol. 2023;16:80. https:\/\/doi.org\/10.1186\/s13045-023-01478-6.","journal-title":"J Hematol Oncol"},{"key":"1807_CR40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.neulet.2017.10.038","volume":"662","author":"R Fern\u00e1ndez-Calle","year":"2018","unstructured":"Fern\u00e1ndez-Calle R, et al. Endogenous pleiotrophin and midkine regulate LPS-induced glial responses. Neurosci Lett. 2018;662:213\u20138. https:\/\/doi.org\/10.1016\/j.neulet.2017.10.038.","journal-title":"Neurosci Lett"},{"key":"1807_CR41","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/joim.13505","volume":"292","author":"CO Stiller","year":"2022","unstructured":"Stiller CO, Hjemdahl P. Lessons from 20 years with COX-2 inhibitors: importance of dose-response considerations and fair play in comparative trials. J Intern Med. 2022;292:557\u201374. https:\/\/doi.org\/10.1111\/joim.13505.","journal-title":"J Intern Med"},{"key":"1807_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/genes12030388","author":"MF Czyzyk-Krzeska","year":"2021","unstructured":"Czyzyk-Krzeska MF, et al. Molecular and metabolic subtypes in sporadic and inherited clear cell renal cell carcinoma. Genes (Basel). 2021. https:\/\/doi.org\/10.3390\/genes12030388.","journal-title":"Genes (Basel)"},{"key":"1807_CR43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.semcdb.2016.09.002","volume":"64","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh JJ, et al. Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: a braided cancer river model of kidney cancer. Semin Cell Dev Biol. 2017;64:98\u2013106. https:\/\/doi.org\/10.1016\/j.semcdb.2016.09.002.","journal-title":"Semin Cell Dev Biol"},{"key":"1807_CR44","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1002\/jcp.29969","volume":"236","author":"Y Lai","year":"2021","unstructured":"Lai Y, et al. The tumour microenvironment and metabolism in renal cell carcinoma targeted or immune therapy. J Cell Physiol. 2021;236:1616\u201327. https:\/\/doi.org\/10.1002\/jcp.29969.","journal-title":"J Cell Physiol"},{"key":"1807_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097946","author":"CU Monjaras-Avila","year":"2023","unstructured":"Monjaras-Avila CU, et al. The tumor immune microenvironment in clear cell renal cell carcinoma. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24097946.","journal-title":"Int J Mol Sci"},{"key":"1807_CR46","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/s0895-7061(96)00381-0","volume":"10","author":"M Rahman","year":"1997","unstructured":"Rahman M, Wright JT Jr, Douglas JG. The role of the cytochrome P450-dependent metabolites of arachidonic acid in blood pressure regulation and renal function: a review. Am J Hypertens. 1997;10:356\u201365. https:\/\/doi.org\/10.1016\/s0895-7061(96)00381-0.","journal-title":"Am J Hypertens"},{"key":"1807_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18122661","author":"TF Borin","year":"2017","unstructured":"Borin TF, Angara K, Rashid MH, Achyut BR, Arbab AS. Arachidonic acid metabolite as a novel therapeutic target in breast cancer metastasis. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18122661.","journal-title":"Int J Mol Sci"},{"key":"1807_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20153683","author":"T Wang","year":"2019","unstructured":"Wang T, et al. Arachidonic acid metabolism and kidney inflammation. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20153683.","journal-title":"Int J Mol Sci"},{"key":"1807_CR49","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao P, et al. CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. 2022;40:365-378.e366. https:\/\/doi.org\/10.1016\/j.ccell.2022.02.003.","journal-title":"Cancer Cell"},{"key":"1807_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.618501","volume":"12","author":"M Xu","year":"2021","unstructured":"Xu M, et al. Arachidonic acid metabolism controls macrophage alternative activation through regulating oxidative phosphorylation in PPAR\u03b3 dependent manner. Front Immunol. 2021;12: 618501. https:\/\/doi.org\/10.3389\/fimmu.2021.618501.","journal-title":"Front Immunol"},{"key":"1807_CR51","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1158\/0008-5472.Can-21-4029","volume":"82","author":"X Chen","year":"2022","unstructured":"Chen X, et al. CYP4F2-catalyzed metabolism of arachidonic acid promotes stromal cell-mediated immunosuppression in non-small cell lung cancer. Cancer Res. 2022;82:4016\u201330. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-4029.","journal-title":"Cancer Res"},{"key":"1807_CR52","doi-asserted-by":"publisher","first-page":"410","DOI":"10.2183\/pjab.86.410","volume":"86","author":"T Muramatsu","year":"2010","unstructured":"Muramatsu T. Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86:410\u201325. https:\/\/doi.org\/10.2183\/pjab.86.410.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"1807_CR53","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1038\/s41388-019-1124-8","volume":"39","author":"PS Filippou","year":"2020","unstructured":"Filippou PS, Karagiannis GS, Constantinidou A. Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target. Oncogene. 2020;39:2040\u201354. https:\/\/doi.org\/10.1038\/s41388-019-1124-8.","journal-title":"Oncogene"},{"key":"1807_CR54","doi-asserted-by":"publisher","first-page":"418","DOI":"10.4049\/jimmunol.0901014","volume":"185","author":"J Kerzerho","year":"2010","unstructured":"Kerzerho J, et al. The angiogenic growth factor and biomarker midkine is a tumor-shared antigen. J Immunol. 2010;185:418\u201323. https:\/\/doi.org\/10.4049\/jimmunol.0901014.","journal-title":"J Immunol"},{"key":"1807_CR55","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.jhep.2021.06.023","volume":"75","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, et al. Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer. J Hepatol. 2021;75:1128\u201341. https:\/\/doi.org\/10.1016\/j.jhep.2021.06.023.","journal-title":"J Hepatol"},{"key":"1807_CR56","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12885-019-5556-x","volume":"19","author":"A Torres","year":"2019","unstructured":"Torres A, et al. CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis. BMC Cancer. 2019;19:401. https:\/\/doi.org\/10.1186\/s12885-019-5556-x.","journal-title":"BMC Cancer"},{"key":"1807_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180511","volume":"12","author":"X Jing","year":"2017","unstructured":"Jing X, Cui X, Liang H, Hao C, Han C. Diagnostic accuracy of ELISA for detecting serum midkine in cancer patients. PLoS ONE. 2017;12: e0180511. https:\/\/doi.org\/10.1371\/journal.pone.0180511.","journal-title":"PLoS ONE"},{"key":"1807_CR58","doi-asserted-by":"publisher","first-page":"24821","DOI":"10.18632\/oncotarget.23892","volume":"9","author":"L Zhang","year":"2018","unstructured":"Zhang L, Song X, Shao Y, Wu C, Jiang J. Prognostic value of Midkine expression in patients with solid tumors: a systematic review and meta-analysis. Oncotarget. 2018;9:24821\u20139. https:\/\/doi.org\/10.18632\/oncotarget.23892.","journal-title":"Oncotarget"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01807-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01807-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01807-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:49:21Z","timestamp":1764917361000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01807-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1807"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01807-8","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"291"}}